Dalteparin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dalteparin and local guidelines before prescribing.
Mechanism
Low molecular weight heparin enhancing antithrombin inhibition of factor Xa.
Uses
VTE prophylaxis and treatment, ACS, cancer-associated VTE, dialysis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Bleeding, injection-site haematoma, thrombocytopenia (HIT), hyperkalaemia, osteoporosis in long-term use.
Interactions
Anticoagulants, antiplatelets and NSAIDs increase bleeding risk.
Contraindications and cautions
Active bleeding, HIT history, acute endocarditis
Monitoring
Platelets, anti-Xa in renal impairment
Pregnancy and breastfeeding
Used in pregnancy
Renal and hepatic impairment
Accumulates in renal impairment
Overdose and reversal
Protamine partially reverses
Special advice
Dose by weight; reduce or monitor anti-Xa in renal impairment; check platelet count on prolonged treatment.
More from the textbook: uses, cautions and other points
- Low molecular weight heparin (enoxaparin, dalteparin, tinzaparin) - subcutaneous, weight-based dosing; mainly anti-Xa ; renally excreted (reduce dose with low creatinine clearance); monitor anti-Xa levels in pregnancy, extremes of weight or CKD; only partly reversed by protamine.
Cardiology: Anatomy Physiology and Pharmacology - Enoxaparin / dalteparin | SC by weight; reduce if CrCl under 30; anti-Xa monitoring in pregnancy, CKD, extreme weight; HIT, hyperkalaemia.
Haematology: Anatomy Physiology and Pharmacology - LMWH (enoxaparin, dalteparin, tinzaparin) | Weight-based; reduce in severe kidney impairment; monitor platelets if exposed to unfractionated heparin recently (HIT); anti-Xa levels in pregnancy, kidney failure or extremes of weight
Haematology: Haemostasis and Thrombosis
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)